知镜 Cognispect · 医学文献与研究工作台

Repositioning of cobalt chloride as a cardioprotective agent against ischemia/reperfusion injury in infant rats.

Gutierrez C, Little T, Ramirez M, Gullino S, Mansisidor A, Jaquenod De Giusti C, Repetto EM, Racioppi F, Bonazzola P, Castilla R.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026-09-08 · PMID 42710319

文献摘要

Reperfusion is essential to prevent further deterioration of ischemic tissue, yet it can paradoxically exacerbate myocardial injury. Ischemia/reperfusion (I/R) injury is particularly relevant in pediatric patients with congenital or acquired heart disease, especially those undergoing cardiac surgery. Cobalt chloride (CoCl₂), an inexpensive compound previously used in humans without documented acute toxicity, has recently been identified as an effective postconditioning agent in adult rat hearts. Given that calcium-handling mechanisms differ between infant and adult myocardium-a key determinant of I/R susceptibility-this study examined whether 0.23 mM CoCl₂ also exerts cardioprotective postconditioning effects in infant rat hearts. Isolated hearts were subjected to global I/R using Langendorff preparation, and functional and structural assessments were performed. Hearts reperfused with CoCl₂, whether throughout the 45-minute reperfusion period or only during the first 5 min, exhibited improved developed tension, along with smaller infarct areas and better-preserved histological features. Under normoxic conditions, CoCl₂ behaved as a reversible negative inotropic agent. These findings support the potential use of CoCl₂ as an economical and clinically relevant cardioprotective strategy for the pediatric population.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。